Work package 5 – Industrialisation

The main objective of this work package is to develop a manufacturing process to produce the selected MV-ZIKA vaccine candidate with high yields and high purity.  This includes:

  • Upstream process optimisations
  • Downstream process optimisations
  • Formulation and Stability

Partners involved:

Themis Bioscience (work package leader)

European Vaccine Initiative (EVI)